XYL
35
-2
ORCL
63
-4
V
64
-2
FAST
57
-3
TJX
62
-2
PEG
62
4
DHR
32
-6
PSA
56
3
GIS
22
-4
UAL
83
-2
AN
50
-5
AME
74
-4
GS
72
4
CTAS
53
-3
JNJ
41
3
MU
28
-3
FSLR
44
-2
DD
53
-6
EXC
54
3
WMB
68
2
XYL
35
-2
ORCL
63
-4
V
64
-2
FAST
57
-3
TJX
62
-2
PEG
62
4
DHR
32
-6
PSA
56
3
GIS
22
-4
UAL
83
-2
AN
50
-5
AME
74
-4
GS
72
4
CTAS
53
-3
JNJ
41
3
MU
28
-3
FSLR
44
-2
DD
53
-6
EXC
54
3
WMB
68
2
Financhill
Back

Bombardier Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
49

BBD.B.TO
Bombardier

Last Price:
90.74
Seasonality Move:
8.45%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
49
Bombardier (BBD.B.TO) is a Sell

Is Bombardier a Buy, Sell or Hold?

  • The current Bombardier [BBD.B.TO] share price is $90.74. The Score for BBD.B.TO is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • BBD.B.TO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BBD.B.TO Stock Price Chart

What is Bombardier's stock price today?

  • The Bombardier share price today is $90.74
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BBD.B.TO is experiencing slight buying pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

BBD.B.TO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.46 Sell
Relative Strength Index (14 RSI): 31.56 Sell
Chaikin Money Flow: 196262 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (97.49 - 108.87) Sell
Bollinger Bands (100): (87 - 102.66) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

BBD.B.TO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 96.89 Sell
20-day SMA: 101.57 Sell
50-day SMA: 99.78 Sell
200-day SMA: 79.98 Buy
8-day EMA: 95.68 Sell
20-day EMA: 99.48 Sell
50-day EMA: 99.06 Sell
200-day EMA: 84 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Bombardier Earnings Growth & BBD.B.TO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.28 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.63 per share, and an increase next year of $3.06 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

Bombardier Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):